Literature DB >> 26620094

Busy Bs.

Howard Trachtman1.   

Abstract

Keywords:  minimal change disease; nephrotic syndrome; rituximab; switched memory B cells

Mesh：

Substances：

Year:  2015        PMID： 26620094      PMCID： PMC4884125          DOI： 10.1681/ASN.2015101171

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  19 in total

1.  Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Authors:  Alessia Fornoni; Junichiro Sageshima; Changli Wei; Sandra Merscher-Gomez; Robier Aguillon-Prada; Alexandra N Jauregui; Jing Li; Adela Mattiazzi; Gaetano Ciancio; Linda Chen; Gaston Zilleruelo; Carolyn Abitbol; Jayanthi Chandar; Wacheree Seeherunvong; Camillo Ricordi; Masami Ikehata; Maria Pia Rastaldi; Jochen Reiser; George W Burke
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

2.  Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.

Authors:  P P Sfikakis; V L Souliotis; K G Fragiadaki; H M Moutsopoulos; J N Boletis; A N Theofilopoulos
Journal:  Clin Immunol       Date:  2007-01-31       Impact factor: 3.969

Review 3.  Effects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiota.

Authors:  Natalie Uy; Lauren Graf; Kevin V Lemley; Frederick Kaskel
Journal:  Pediatr Res       Date:  2014-10-13       Impact factor: 3.756

4.  Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome.

Authors:  Shori Takahashi; Naohiro Wada; Hitohiko Murakami; Satoshi Funaki; Tetsuji Inagaki; Kensuke Harada; Michio Nagata
Journal:  Pediatr Nephrol       Date:  2006-10-17       Impact factor: 3.714

5.  Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.

Authors:  Biswanath Basu; T K S Mahapatra; Nirmal Mondal
Journal:  Pediatrics       Date:  2015-07       Impact factor: 7.124

6.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

7.  Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

Authors:  Piero Ruggenenti; Barbara Ruggiero; Paolo Cravedi; Marina Vivarelli; Laura Massella; Maddalena Marasà; Antonietta Chianca; Nadia Rubis; Bogdan Ene-Iordache; Michael Rudnicki; Rosa Maria Pollastro; Giovambattista Capasso; Antonio Pisani; Marco Pennesi; Francesco Emma; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 10.121

8.  Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

Authors:  Pietro Ravani; Alessandro Ponticelli; Chiara Siciliano; Alessia Fornoni; Alberto Magnasco; Felice Sica; Monica Bodria; Gianluca Caridi; Changli Wei; Mirco Belingheri; Luciana Ghio; Sandra Merscher-Gomez; Alberto Edefonti; Andrea Pasini; Giovanni Montini; Corrado Murtas; Xiangyu Wang; Daniel Muruve; Augusto Vaglio; Davide Martorana; Antonello Pani; Francesco Scolari; Jochen Reiser; Gian M Ghiggeri
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

9.  B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.

Authors:  Manuela Colucci; Rita Carsetti; Simona Cascioli; Federica Casiraghi; Annalisa Perna; Lucilla Ravà; Barbara Ruggiero; Francesco Emma; Marina Vivarelli
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

10.  Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.

Authors:  Shuichiro Fujinaga; Daishi Hirano; Naoto Nishizaki; Koichi Kamei; Shuichi Ito; Yoshiyuki Ohtomo; Toshiaki Shimizu; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2010-01-05       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.